Reported 3 months ago
South Korea's government announced plans to bolster its biopharmaceutical and automotive sectors, which are likely to face challenges due to U.S. tariffs imposed by President Trump. As the U.S. seeks to enhance domestic pharmaceutical manufacturing, South Korea prepares measures to support its exports, particularly in light of the 16% of biopharmaceutical products shipped to the U.S. The country aims to negotiate tariff exemptions while also aiding other affected industries like chipmakers and steel manufacturers.
Source: YAHOO